235 related articles for article (PubMed ID: 25810396)
21. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.
Sonnenblick A; Levy C; Razin E
Mol Cell Biol; 2004 Dec; 24(24):10584-92. PubMed ID: 15572665
[TBL] [Abstract][Full Text] [Related]
22. A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells.
Proulx-Bonneau S; Guezguez A; Annabi B
PLoS One; 2011; 6(6):e21511. PubMed ID: 21738685
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis.
Lyberg K; Ali HA; Grootens J; Kjellander M; Tirfing M; Arock M; Hägglund H; Nilsson G; Ungerstedt J
Oncotarget; 2017 Feb; 8(6):9647-9659. PubMed ID: 28038453
[TBL] [Abstract][Full Text] [Related]
24. C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation.
Phung B; Sun J; Schepsky A; Steingrimsson E; Rönnstrand L
PLoS One; 2011; 6(8):e24064. PubMed ID: 21887372
[TBL] [Abstract][Full Text] [Related]
25. The transcription factors GATA2 and microphthalmia-associated transcription factor regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis.
Li Y; Liu B; Harmacek L; Long Z; Liang J; Lukin K; Leach SM; O'Connor B; Gerber AN; Hagman J; Roers A; Finkelman FD; Huang H
J Allergy Clin Immunol; 2018 Oct; 142(4):1173-1184. PubMed ID: 29277702
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity.
Macleod AC; Klug LR; Patterson J; Griffith DJ; Beadling C; Town A; Heinrich MC
Mol Cancer Ther; 2014 Dec; 13(12):2840-51. PubMed ID: 25253785
[TBL] [Abstract][Full Text] [Related]
27. Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Sabbah M; Krayem M; Najem A; Sales F; Miller W; Del Rincon S; Awada A; Ghanem GE; Journe F
Mol Cancer Res; 2021 Jul; 19(7):1221-1233. PubMed ID: 33741716
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
29. Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells.
Chihara K; Kato Y; Yoshiki H; Takeuchi K; Fujieda S; Sada K
Sci Rep; 2017 Sep; 7(1):11480. PubMed ID: 28904407
[TBL] [Abstract][Full Text] [Related]
30. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr WR; Kopp C; Sillaber C; Semper H; Horny HP; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
Wien Klin Wochenschr; 1998 Feb; 110(3):79-88. PubMed ID: 9553202
[TBL] [Abstract][Full Text] [Related]
31. Regulation of mast cell phenotype by MITF.
Kitamura Y; Morii E; Jippo T; Ito A
Int Arch Allergy Immunol; 2002 Feb; 127(2):106-9. PubMed ID: 11919417
[TBL] [Abstract][Full Text] [Related]
32. Requirement of c-jun transcription factor on the mouse mast cell protease-6 expression in the mast cells.
Kim DK; Lee YM
Arch Biochem Biophys; 2004 Nov; 431(1):71-8. PubMed ID: 15464728
[TBL] [Abstract][Full Text] [Related]
33. Additive effect of mouse genetic background and mutation of MITF gene on decrease of skin mast cells.
Morii E; Oboki K; Jippo T; Kitamura Y
Blood; 2003 Feb; 101(4):1344-50. PubMed ID: 12393515
[TBL] [Abstract][Full Text] [Related]
34. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
35. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.
Timokhina I; Kissel H; Stella G; Besmer P
EMBO J; 1998 Nov; 17(21):6250-62. PubMed ID: 9799234
[TBL] [Abstract][Full Text] [Related]
36. Immunological trigger of mast cells by monomeric IgE: effect on microphthalmia transcription factor, STAT3 network of interactions.
Sonnenblick A; Levy C; Razin E
J Immunol; 2005 Aug; 175(3):1450-5. PubMed ID: 16034081
[TBL] [Abstract][Full Text] [Related]
37. Importance of leucine zipper domain of mi transcription factor (MITF) for differentiation of mast cells demonstrated using mi(ce)/mi(ce) mutant mice of which MITF lacks the zipper domain.
Morii E; Ogihara H; Kim DK; Ito A; Oboki K; Lee YM; Jippo T; Nomura S; Maeyama K; Lamoreux ML; Kitamura Y
Blood; 2001 Apr; 97(7):2038-44. PubMed ID: 11264169
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
39. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.
De Sepulveda P; Okkenhaug K; Rose JL; Hawley RG; Dubreuil P; Rottapel R
EMBO J; 1999 Feb; 18(4):904-15. PubMed ID: 10022833
[TBL] [Abstract][Full Text] [Related]
40. The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms.
Saborit-Villarroya I; Martinez-Barriocanal A; Oliver-Vila I; Engel P; Sayos J; Martin M
Mol Immunol; 2008 Jul; 45(12):3446-53. PubMed ID: 18479751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
